Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multi-Center Study of Tolerability, Safety and Efficacy of Sensory Stimulation at Multiple Dose Levels to Improve Brain Function (Etude Study)

NCT03661034 is registered in ClinicalTrials.gov with Cognito Therapeutics, Inc. as lead sponsor.

NCT NCT03661034
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03661034 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multi-Center Study of Tolerability, Safety and Efficacy of Sensory Stimulation at Multiple Dose Levels to Improve Brain Function (Etude Study)
Lead sponsor
Cognito Therapeutics, Inc.
Phase
Not applicable
Overall status
Unknown status
Start date
May 31, 2018
Completion date
March 1, 2022
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer dementia, alzheimer disease, alzheimer disease, early onset, alzheimer disease, late onset, cognitive decline, cognitive impairment, dementia, alzheimer type, dementia, mild, memory disorders, memory disorders, age related, memory impairment, memory loss, mild cognitive impairment